ALTAMURA, CLAUDIA
 Distribuzione geografica
Continente #
AS - Asia 5.858
NA - Nord America 753
EU - Europa 493
SA - Sud America 204
AF - Africa 17
OC - Oceania 13
AN - Antartide 1
Totale 7.339
Nazione #
SG - Singapore 4.832
US - Stati Uniti d'America 716
CN - Cina 438
HK - Hong Kong 415
BR - Brasile 164
IT - Italia 145
GB - Regno Unito 124
VN - Vietnam 82
DE - Germania 75
CA - Canada 25
IN - India 25
EE - Estonia 22
NL - Olanda 22
FI - Finlandia 19
ID - Indonesia 19
AR - Argentina 16
AT - Austria 15
AU - Australia 12
JP - Giappone 10
UA - Ucraina 10
EC - Ecuador 9
SE - Svezia 9
TR - Turchia 9
ES - Italia 8
FR - Francia 8
MX - Messico 8
RU - Federazione Russa 8
ZA - Sudafrica 8
CZ - Repubblica Ceca 6
PL - Polonia 6
BD - Bangladesh 5
CO - Colombia 5
KZ - Kazakistan 4
LT - Lituania 4
HR - Croazia 3
KR - Corea 3
PE - Perù 3
PY - Paraguay 3
SA - Arabia Saudita 3
CL - Cile 2
GR - Grecia 2
MA - Marocco 2
PK - Pakistan 2
PT - Portogallo 2
TW - Taiwan 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BO - Bolivia 1
CG - Congo 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LV - Lettonia 1
MS - Montserrat 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
SN - Senegal 1
SO - Somalia 1
SV - El Salvador 1
TN - Tunisia 1
VE - Venezuela 1
YT - Mayotte 1
Totale 7.339
Città #
Hong Kong 409
Hefei 237
Singapore 194
Ashburn 157
Dallas 121
Boardman 113
London 105
Beijing 93
Shanghai 78
Ho Chi Minh City 30
Munich 29
Rome 29
San Francisco 25
Los Angeles 24
Sona 22
Council Bluffs 21
Hanoi 20
Santa Clara 18
São Paulo 18
Amsterdam 13
Pune 13
Seattle 13
Washington 11
Helsinki 10
New York 10
Nuremberg 10
Toronto 10
West Jordan 10
Florence 9
Montreal 9
Redmond 9
Stockholm 8
Tokyo 8
Turku 8
Chennai 7
Milan 7
Brasília 6
Brno 6
Warsaw 6
Boston 5
Edinburgh 5
Istrana 5
Melbourne 5
Quito 5
Santa Fe 5
Vienna 5
Bologna 4
Brooklyn 4
Chicago 4
Frankfurt am Main 4
Mexico City 4
Phoenix 4
Rio de Janeiro 4
Sydney 4
Turin 4
Caivano 3
Central 3
Centro 3
Charlotte 3
Feira de Santana 3
Fiesole 3
Guayaquil 3
Johannesburg 3
Lima 3
Manchester 3
Miami 3
Niterói 3
Novara 3
Providence 3
Riyadh 3
Vũng Tàu 3
Ankara 2
Athens 2
Bari 2
Barra Mansa 2
Buenos Aires 2
Bungarribee 2
Bắc Giang 2
Can Tho 2
Canberra 2
Cardiff 2
Ciampino 2
Cinisello Balsamo 2
Contagem 2
Curitiba 2
Da Nang 2
Fragagnano 2
Guangzhou 2
Jakarta 2
Lake Zurich 2
Manaus 2
Mariano Moreno 2
Moscow 2
Occimiano 2
Oklahoma City 2
Palermo 2
Porto 2
Ribeirão Preto 2
Riccione 2
San Giovanni Rotondo 2
Totale 2.103
Nome #
1-Hz repetitive transcranial magnetic stimulation increases cerebral vasomotor reactivity: a possible autonomic nervous system modulation 332
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 220
Hyperhomocysteinemia, intima-media thickness and C677T MTHFR gene polymorphism: A correlation study in patients with cognitive impairment 203
Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment 197
Task-switching abilities in episodic and chronic migraine 195
Psychopathological variables in chronic migraine patients with different therapeutic approach: psychological profile differences and impact on therapeutic efficacy in real life 194
Acute Carotid Dissection in an Adult Caused by Pertussis 194
Correction to: Task-switching abilities in episodic and chronic migraine (Neurological Sciences, (2022), 10.1007/s10072-021-05837-4) 192
Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real-life perspective from the Italian chROnic migraiNe (IRON) project 187
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 186
OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study 181
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study 179
Cerebral Hemodynamics, Right-to-Left Shunt and White Matter Hyperintensities in Patients with Migraine with Aura, Young Stroke Patients and Controls 176
Stroke territory and atherosclerosis in ischemic stroke patients with a history of migraine with aura 172
Cerebral distribution of white matter lesions in migraine with aura patients 172
CAROTID WALL THICKNESS AND STROKE RISK IN PATIENTS WITH ASYMPTOMATIC INTERNAL CAROTID STENOSIS 169
Cerebral vasomotor reactivity in the acute phase and after 6 months in non-disabling stroke/TIA: A prospective cohort study 162
Right-to-Left Shunt and the Clinical Features of Migraine with Aura: Earlier but Not More 161
Eptinezumab for the Prevention of Migraine: Clinical Utility, Patient Preferences and Selection - A Narrative Review 160
Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment 151
Cerebral Hemodynamics, Patent foramen ovale and White Matter Hyperintensities in patients Migraine with aura, young stroke patients and controls 119
Frequency and clinical implications of hypercoagulability states in a cohort of patients with migraine with aura 108
Antioxidant status and APOE genotype as susceptibility factors for neurodegeneration in Alzheimer's disease and vascular dementia 87
Bilateral MCP Infarct Due to Vertebral Giant Cell Arteritis 87
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study 86
Carotid Artery Plaque Progression: Proposal of a New Predictive Score and Role of Carotid Intima-Media Thickness 86
Embodying an artificial hand increases blood flow to the investigated limb [version 3; peer review: 2 approved] 85
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 85
Acute medications' intake for migraine: a one-year report in patients undergoing first evaluation at a third level Italian headache center 82
Cerebrovascular reactivity predicts stroke in high-grade carotid artery disease 82
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 81
Relationship among diffusion tensor imaging, EEG activity, and cognitive status in mild cognitive impairment and Alzheimer's disease patients 80
Ceruloplasmin/Transferrin system is related to clinical status in acute stroke 78
Regional MRI Diffusion, White-Matter Hyperintensities, and Cognitive Function in Alzheimer's Disease and Vascular Dementia 78
Gepants - a long way to cure: a narrative review 76
Carotid atherosclerosis and cognitive decline in patients with Alzheimer's disease 75
Cerebrovascular assessment for the risk prediction of Alzheimer's disease 75
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study 74
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study 73
Blood pressure monitoring in elderly migraineurs starting an anti-CGRP monoclonal antibody: a real-world prospective study 72
Effects of prophylactic drug therapies and anti-calcitonin peptide-related monoclonal antibodies on subjective sleep quality: An Italian multicenter study 70
Diffusion-weighted lesions after carotid artery stenting are associated with cognitive impairment 70
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study 65
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) 57
Patients with migraine with aura have increased flow mediated dilation 42
Calcitonin Gene-Related Peptide Systemic Effects: Embracing the Complexity of Its Biological Roles-A Narrative Review 39
Vascular predictors of cognitive decline in patients with mild cognitive impairment 36
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study 34
Cortical neuromodulation modifies cerebral vasomotor reactivity 32
The Healthy Eating Plate Advice for Migraine Prevention: An Interventional Study 32
The role of endothelial dysfunction in the pathophysiology and cerebrovascular effects of migraine: A narrative review 32
When should we consider chronic patients as non-responders to monoclonal antibodies targeting the CGRP pathway? 31
Gadolinium Enhancement in a Case of Uncomplicated Posterior Reversible Encephalopathy Syndrome 30
Emerging Risk Factors for Dementia: The Role of Blood Pressure Variability 29
Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) 28
Dorsolateral medullary ischemic infarction causing autonomic dysfunction and headache: a case report 28
Ruolo delle mappe ADC nella diagnosi differenziale tra demenza vascolare e demenza di Alzheimer 28
fMRI-vs-MEG evaluation of post-stroke interhemispheric asymmetries in primary sensorimotor hand areas 28
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience 28
Cortical ischemic lesion burden measured by DIR is related to carotid artery disease severity 27
Cognitive performance is related to ceruloplasmin/transferrin system in patients with chronic hepatitis 27
Does cerebrovascular disease affect the coupling between neuronal activity and local haemodynamics? 27
Shorter visual aura characterizes young and middle-aged stroke patients with migraine with aura 27
Serotonin depletion and barrel cortex development: impact of growth impairment vs. serotonin effects on thalamocortical endings 26
Patent foramen ovale and migraine with aura in a retrospective analysis: age matters 26
Internal jugular vein valve incompetence in transient global amnesia: more circumstantial evidence or the proof solving the mystery? 26
Pathophysiological Bases of Comorbidity in Migraine 26
The Role of White Matter Damage in the Risk of Periprocedural Diffusion-Weighted Lesions after Carotid Artery Stenting. 25
Neuroimaging experimental studies on brain plasticity in recovery from stroke 25
Markers for the risk of progression from mild cognitive impairment to Alzheimer's disease 25
What is the relationship among atherosclerosis markers, apolipoprotein E polymorphism and dementia? 25
Thresholds of impaired cerebral hemodynamics that predict short-term cognitive decline in asymptomatic carotid stenosis 25
Commentary: Enhanced Hemodynamic and Clinical Response to αCGRP in Migraine Patients—A TCD Study 25
Markers of lacunar stroke in patients with moderate internal carotid artery stenosis 24
Daith Piercing in a Case of Chronic Migraine: A Possible Vagal Modulation 23
Hemoglobin oxygen saturation as a marker of cerebral hemodynamics in carotid artery occlusion : An integrated transcranial doppler and near-infrared spectroscopy study 22
Neuronal functionality assessed by magnetoencephalography is related to oxidative stress system in acute ischemic stroke 22
High frequency repetitive transcranial magnetic stimulation decreases cerebral vasomotor reactivity 22
Transient global amnesia and jugular vein incompetence response 21
Right-to-left shunts and hormonal therapy influence cerebral vasomotor reactivity in patients with migraine with aura 21
One-year progression of moderate asymptomatic carotid stenosis predicts the risk of vascular events 21
Postpartum cerebellar infarction and haemolysis, elevated liver enzymes, low platelet (HELLP) syndrome 21
Early activation of intracranial collateral vessels influences the outcome of spontaneous internal carotid artery dissection 21
Onabotulinumtoxin-A in Chronic Migraine: Should Timing and Definition of Non-Responder Status Be Revised? Suggestions From a Real-Life Italian Multicenter Experience 21
Gender Differences in 3-Month Outcomes of Erenumab Treatment—Study on Efficacy and Safety of Treatment With Erenumab in Men 21
Ultrasonographic markers of vascular risk in patients with asymptomatic carotid stenosis 20
Poor sleep quality in patients affected by migraine: a population study 20
Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study) 20
Excessive daytime sleepiness is associated to the development of swallowing impairment in a cohort of early stage drug naïve Parkinson's disease patients 20
The evolving concept of multimorbidity and migraine 20
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study 19
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients 19
Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study 19
Reducing the Impact of Headache and Allodynia Score in Chronic Migraine: An Exploratory Analysis from the Real-World Effectiveness of Anti-CGRP Monoclonal Antibodies Compared to Onabotulinum Toxin A (RAMO) Study 19
Influence of chronotype on migraine characteristics 19
Severe carotid stenosis and impaired cerebral hemodynamics can influence cognitive deterioration 19
Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study 19
Promoting healthy eating can help preventing migraine: a real-life preliminary study 18
Lack of correlation between cerebral vasomotor reactivity and flow-mediated dilation in subjects without vascular disease 18
Sex-associated differences in themodulation of vascular risk in patients with asymptomatic carotid stenosis 17
Totale 7.099
Categoria #
all - tutte 43.989
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.989


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022131 0 0 3 0 0 0 0 0 17 4 0 107
2022/202366 2 2 2 2 7 4 4 11 7 4 17 4
2023/2024348 17 40 12 31 36 144 5 27 6 10 9 11
2024/20255.796 43 44 123 11 14 68 106 62 322 411 2.235 2.357
2025/20261.034 371 258 339 66 0 0 0 0 0 0 0 0
Totale 7.375